ABCG2 and cancer: Over-expression of MRP, BCRP and P-gp, as a classical drug resistance mechanism, can increase the efflux capacity of cells to chemotherapeutic drugs, making drug accumulation decrease or even disappear and then reducing the toxicity to cancer cells [31].